Advertisement
Advertisement

NEUP

NEUP logo

Neuphoria Therapeutics Inc. Common Stock

5.31
USD
Sponsored
-0.03
-0.56%
May 08, 15:59 UTC -4
Closed
exchange

After-Market

5.28

-0.03
-0.66%

Neuphoria Therapeutics Inc. Common Stock Profile

About

Bionomics Limited is a clinical-stage biopharmaceutical developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system disorders. Bionomics Limited is based in ADELAIDE, Australia.

Info & Links

CEO

Spyridon Papapetropoulos

Headquarters

100 SUMMIT DRIVE
BURLINGTON, MA 01803, AUSTRALIA

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.neuphoriatx.com

Auditor

Wolf & Company PC

Share holders

--

Employees

8

Neuphoria Therapeutics Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

28.44M

Enterprise Value

6.19M

Enterprise Value/EBITDA(ttm)

-2.13

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.85

Price to Cash(ytd)

30.28

Profitability

Gross Margin(ttm)

50.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

16759.39%

Return on Equity(ttm)

-25.98%

Return on Invested Capital(ttm)

-76.34%

Return on Assets(ttm)

-18.39%

Income Statement

Revenue(ttm)

14.99M

Revenue Per Share(ttm)

2.78

Gross Profit(ttm)

14.99M

EBITDA(ttm)3

-2.91M

Net Income Available to Common(ttm)

-5.66M

Diluted EPS(ttm)

-4.42

Share Statistics

Beta (5Y Monthly)

0.48

52-Week Change

7.49%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

5.39M

Dividend Yield

0.00%

Float4

5.31M

% Held by Insiders

1.50%

% Held by Institutions

15.90%

Balance Sheet

Total Cash(mrq)

22.25M

Total Cash Per Share(mrq)

4.13

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

9.04%

Quick Ratio(mrq)

9.04%

Book Value Per Share(mrq)

5.52

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.26

Free Cash Flow(ytd)

-10.23M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement